Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database-Reference-Cited by-同舟云学术

Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database

Published:2014-11-12 Issue:3 Volume:22 Page:464-471
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Blin P.¹²^ORCID,Dureau-Pournin C.¹²,Foubert-Samier A.³⁴,Grolleau A.²⁵,Corbillon E.⁶,Jové J.¹²,Lassalle R.¹²,Robinson P.¹²,Poutignat N.⁶,Droz-Perroteau C.¹²,Moore N.²⁴⁵⁷

Affiliation:

1. Adera; Pessac France

2. CIC Bordeaux CIC1401; Bordeaux France

3. INSERM U897; ISPED; Bordeaux France

4. CHU Bordeaux; Bordeaux France

5. Univ. Bordeaux; Bordeaux France

6. Haute Autorité de Santé; St Denis La Plaine France

7. INSERM U657; Bordeaux France

Funder

Haute AutoritÃ© de SantÃ©

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12592/fullpdf

Reference21 articles.

1. Parkinson's disease;Samii;Lancet,2004

2. A review of Parkinson's disease;Davie;Br Med Bull,2008

3. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group;Rijk;Neurology,2000

4. Moisan F Elbaz A Maladie de Parkinson parmi les affiliés à la Mutualité sociale agricole dans cinq départements 2012 http://www.invs.sante.fr

5. Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France;Tison;Acta Neurol Scand,1994

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Disturbances in a Mouse Model of MPTP/Probenecid-Induced Parkinson’s Disease: Evaluation Using Liquid Chromatography-Mass Spectrometry;Neuropsychiatric Disease and Treatment;2024-08

2. Incidence of Parkinson’s disease in Germany based on prevalence data from 70 million patients of the statutory health insurance;BMC Neurology;2024-06-27

3. The molecular mechanism of aging and the role in neurodegenerative diseases;Heliyon;2024-01

4. Prevalence, demographic and spatial distribution of treated epilepsy in France in 2020: a study based on the French national health data system;Journal of Neurology;2023-10-03

5. Application of mesenchymal stem cells (MSCs) in neurodegenerative disorders: History, findings, and prospective challenges;Pathology - Research and Practice;2023-07